Price Chart

Profile

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.
URL https://www.tilray.com
Investor Relations URL https://ir.tilray.com/
HQ State/Province Ontario
Sector Health Care
Industry Pharmaceuticals
Equity Style Small Cap/Value
Next Earnings Release Jan. 09, 2025
Last Earnings Release Oct. 10, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.
URL https://www.tilray.com
Investor Relations URL https://ir.tilray.com/
HQ State/Province Ontario
Sector Health Care
Industry Pharmaceuticals
Equity Style Small Cap/Value
Next Earnings Release Jan. 09, 2025
Last Earnings Release Oct. 10, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A